TAK-063
- CAS No.1238697-26-1
- Chemical Name:TAK-063
- CBNumber:CB62735539
- Molecular Formula:C23H17FN6O2
- Formula Weight:428.42
- MOL File:1238697-26-1.mol
- Boiling point 612.3±65.0 °C(Predicted)
- Density 1.37±0.1 g/cm3(Predicted)
- storage temp. Store at -20°C
- solubility DMSO:55.0(Max Conc. mg/mL);128.38(Max Conc. mM)
- form A crystalline solid
- pka -0.34±0.12(Predicted)
- color Light yellow to yellow
- FDA UNII 6650W303H0
-
Symbol(GHS)
- Signal wordWarning
- Hazard statements H302-H315-H319-H335
- Precautionary statements P261-P305+P351+P338
TAK-063 Chemical Properties,Usage,Production
- Description TAK-063 is a potent inhibitor of phosphodiesterase 10A (PDE10A; IC50 = 0.3 nM). It is >15,000-fold selective for PDE10A over other PDEs and exhibits <50% inhibition at 91 receptors, ion channels, and enzymes at a concentration of 10 μM. TAK-063 (0.3 mg/kg) increases cAMP and cGMP levels by 1.3- and 2.14-fold, respectively, in the striatum of mice. It reverses hyperlocomotion induced by PCP (Item Nos. 14276 | ISO60194) with a minimum effective dose (MED) of 0.3 mg/kg, p.o., in wild-type mice but has no effect in PDE10A knockout mice at doses up to 1 mg/kg. TAK-063 also reverses hyperlocomotion induced by (+)-MK-801 (MED = 0.1 mg/kg, p.o.) but has no effect on plasma prolactin or glucose levels in rats.
- Uses Balipodect (TAK-063) is a highly potent, selective and orally active PDE10A inhibitor with IC50 of 0.30 nM; >15000-fold selectivity over other PDEs.
-
in vivo
Balipodect (TAK-063) has excellent selectivity (>15000-fold selectivity over other PDEs), and favorable pharmacokinetics, including high brain penetration, in mice. Oral administration of Balipodect (TAK-063) to mice elevated striatal 3',5'-cyclic adenosine monophosphate (cAMP) and 3',5'-cyclic guanosine monophosphate (cGMP) levels at 0.3 mg/kg and showed potent suppression of phencyclidine (PCP)-induced hyperlocomotion at a minimum effective dose (MED) of 0.3 mg/kg[1].Balipodect (TAK-063) at 0.3 and 1 mg/kg, p.o., increased cAMP and cGMP levels in the rodent striatum and upregulated phosphorylation levels of key substrates of cAMP-dependent and cGMP-dependent protein kinases. Balipodect (TAK-063) at 0.3 and 1 mg/kg, p.o., strongly suppressed MK-801-induced hyperlocomotion that is often used as a predictive model for antipsychotic-like activity in rodents. Balipodect (TAK-063) did not affect plasma prolactin or glucose levels at doses up to 3 mg/kg, p.o. Balipodect (TAK-063) at 3 mg/kg, p.o., elicited a weak cataleptic response compared with haloperidol and olanzapine[2].
- IC 50 PDE10
-
References
[1] Kunitomo J, et al. Discovery of 1-[2-Fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one (TAK-063), a Highly Potent, Selective, and Orally Active Phosphodiesterase 10A (PDE10A) Inhibitor. J Med Chem. 2014 Nov 26;57(22):9627-43. DOI:10.1021/jm5013648
[2] Suzuki K, et al. In Vivo Pharmacological Characterization of TAK-063, a Potent and Selective Phosphodiesterase 10A Inhibitor with Antipsychotic-Like Activity in Rodents. J Pharmacol Exp Ther. 2014 Dec 18. pii: jpet.114.218552. DOI:10.1124/jpet.114.218552
-
Supplier:
- Tel:+undefined-21-51877795
- Email:ivan@atkchemical.com
- Country:China
- ProdList:33024
- Advantage:60
-
Supplier:
- Tel:+86-0371-86658258<br/>+8613203830695
- Email:factory@coreychem.com
- Country:China
- ProdList:29808
- Advantage:58
-
Supplier:
- Tel:+1-781-999-5354<br/>+1-00000000000
- Email:marketing@targetmol.com
- Country:United States
- ProdList:32159
- Advantage:58
-
Supplier:
- Tel:86-571-88216897,88216896<br/>13588875226
- Email:sales@hzclap.com
- Country:CHINA
- ProdList:6312
- Advantage:58
-
Supplier:
- Tel:755-85269922<br/>+8613424394241
- Email:sales@shengdapharm.com
- Country:CHINA
- ProdList:310
- Advantage:58
-
Supplier:
- Tel:+1-2135480471<br/>+1-2135480471
- Email:sales@sarms4muscle.com
- Country:China
- ProdList:10473
- Advantage:58
-
Supplier:
- Tel:+1-708-310-1919<br/>+1-13798911105
- Email:sales@invivochem.cn
- Country:United States
- ProdList:6391
- Advantage:58
-
Supplier:
- Tel: 13417589054
- Email:trendseenbio@gmail.com
- Country:China
- ProdList:11681
- Advantage:58
-
Supplier:
- Tel:+86-852-30606658
- Email:market18@leapchem.com
- Country:China
- ProdList:43340
- Advantage:58
-
Supplier:
- Tel:
- Email:tp@aladdinsci.com
- Country:United States
- ProdList:57505
- Advantage:58
- Inhibitors
- 化学试剂
- 药靶配体
- 小分子抑制剂
- 抑制剂
- 小分子抑制剂,天然产物
- C23H17FN6O2
- 化合物TAK-063,10 MM DMSO 溶液
- 化合物TAK-063
- 化合物 BALIPODECT
- 1-[2-氟-4-(1H-吡唑-1-基)苯基]-5-甲氧基-3-(1-苯基-1H-吡唑-5-基)哒嗪-4(1H)-酮
- 1238697-26-1
- Balipodect, 10 mM in DMSO
- 4(1H)-Pyridazinone, 1-[2-fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)-
- TAK063, TAK 063, TAK-063, BALIPODECT
- TAK-063(Balipodect)
- CS-1534
- Pyridone 6[1-[2-fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one]
- TAK 063;TAK063
- Balipodect
- 1-[2-Fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one
- TAK-063